Thymosin Alpha-1
Strengthen immune defense and modulate immune response.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Thymosin Alpha-1
Thymosin Alpha-1 is a peptide naturally produced by the thymus gland. It is critical for the maturation of T-cells and the coordination of immune response. It has been used clinically in over 35 countries for chronic hepatitis B and C, and as an immune adjuvant.
Key Benefits
- Enhances T-cell function
- Supports innate and adaptive immunity
- May improve vaccine efficacy
- Modulates inflammatory cytokines
Set a goal (top of the page) to see how Thymosin Alpha-1 scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Injection site discomfort
- Mild fatigue
- Rare allergic reaction
Legal & Regulatory Status
Research use only in the US (FDA orphan-drug designations only). Approved as thymalfasin/Zadaxin in 35+ countries for hepatitis B/C and as an immune adjuvant; supported by human RCTs (mostly for sepsis/hepatitis).
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
- ETASS: multicenter RCT of thymosin α1 for severe sepsis (PMC4056079)
- Thymosin α1 for sepsis — systematic review of RCTs (PMC5025565)
Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.
